Recent proteome and functional analyses reveal that, in human cancers, including prostate cancer, TUBB4A is involved with cell structural and tubulin-binding processes and resistance to chemo- and radio-therapy13–16. This evidence concerns the gene TUBB4A and prostate carcinoma.